These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21653641)

  • 1. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex.
    Zuvich RL; Bush WS; McCauley JL; Beecham AH; De Jager PL; ; Ivinson AJ; Compston A; Hafler DA; Hauser SL; Sawcer SJ; Pericak-Vance MA; Barcellos LF; Mortlock DP; Haines JL
    Hum Mol Genet; 2011 Sep; 20(17):3517-24. PubMed ID: 21653641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
    Leikfoss IS; Keshari PK; Gustavsen MW; Bjølgerud A; Brorson IS; Celius EG; Spurkland A; Bos SD; Harbo HF; Berge T
    PLoS One; 2015; 10(7):e0132957. PubMed ID: 26203907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
    Leikfoss IS; Mero IL; Dahle MK; Lie BA; Harbo HF; Spurkland A; Berge T
    Genes Immun; 2013 Jan; 14(1):62-6. PubMed ID: 23151489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.
    Skinningsrud B; Husebye ES; Pearce SH; McDonald DO; Brandal K; Wolff AB; Løvås K; Egeland T; Undlien DE
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3310-7. PubMed ID: 18593762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.
    Hirschfield GM; Xie G; Lu E; Sun Y; Juran BD; Chellappa V; Coltescu C; Mason AL; Milkiewicz P; Myers RP; Odin JA; Luketic VA; Bacon B; Bodenheimer H; Liakina V; Vincent C; Levy C; Pillai S; Lazaridis KN; Amos CI; Siminovitch KA
    Genes Immun; 2012 Jun; 13(4):328-35. PubMed ID: 22257840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More CLEC16A gene variants associated with multiple sclerosis.
    Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
    Acta Neurol Scand; 2011 Jun; 123(6):400-6. PubMed ID: 20849399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
    Mero IL; Ban M; Lorentzen ÅR; Smestad C; Celius EG; Sæther H; Saeedi H; Viken MK; Skinningsrud B; Undlien DE; Aarseth J; Myhr KM; Granum S; Spurkland A; Sawcer S; Compston A; Lie BA; Harbo HF
    Genes Immun; 2011 Apr; 12(3):191-8. PubMed ID: 21179112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping and functional studies of risk variants for type 1 diabetes at chromosome 16p13.13.
    Tomlinson MJ; Pitsillides A; Pickin R; Mika M; Keene KL; Hou X; Mychaleckyj J; Chen WM; Concannon P; Onengut-Gumuscu S
    Diabetes; 2014 Dec; 63(12):4360-8. PubMed ID: 25008175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal region 16p13: further evidence of increased predisposition to immune diseases.
    Martínez A; Perdigones N; Cénit MC; Espino L; Varadé J; Lamas JR; Santiago JL; Fernández-Arquero M; de la Calle H; Arroyo R; de la Concha EG; Fernández-Gutiérrez B; Urcelay E
    Ann Rheum Dis; 2010 Jan; 69(1):309-11. PubMed ID: 19221398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.
    Vandenbroeck K; Alvarez J; Swaminathan B; Alloza I; Matesanz F; Urcelay E; Comabella M; Alcina A; Fedetz M; Ortiz MA; Izquierdo G; Fernandez O; Rodriguez-Ezpeleta N; Matute C; Caillier S; Arroyo R; Montalban X; Oksenberg JR; Antigüedad A; Aransay A
    Genes Immun; 2012 Jan; 13(1):21-8. PubMed ID: 21716315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis.
    van Luijn MM; Kreft KL; Jongsma ML; Mes SW; Wierenga-Wolf AF; van Meurs M; Melief MJ; der Kant Rv; Janssen L; Janssen H; Tan R; Priatel JJ; Neefjes J; Laman JD; Hintzen RQ
    Brain; 2015 Jun; 138(Pt 6):1531-47. PubMed ID: 25823473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese.
    Awata T; Kawasaki E; Tanaka S; Ikegami H; Maruyama T; Shimada A; Nakanishi K; Kobayashi T; Iizuka H; Uga M; Kawabata Y; Kanazawa Y; Kurihara S; Osaki M; Katayama S;
    J Clin Endocrinol Metab; 2009 Jan; 94(1):231-5. PubMed ID: 18940880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk alleles for multiple sclerosis in multiplex families.
    D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
    Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
    J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune disease association signals in CIITA and KIAA0350 are not involved in celiac disease susceptibility.
    Dema B; Martínez A; Fernández-Arquero M; Maluenda C; Polanco I; Angeles Figueredo M; de la Concha EG; Urcelay E; Núñez C
    Tissue Antigens; 2009 Apr; 73(4):326-9. PubMed ID: 19317741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.
    Caillier SJ; Briggs F; Cree BA; Baranzini SE; Fernandez-Viña M; Ramsay PP; Khan O; Royal W; Hauser SL; Barcellos LF; Oksenberg JR
    J Immunol; 2008 Oct; 181(8):5473-80. PubMed ID: 18832704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of the multiple sclerosis susceptibility gene CLEC16A in T cells.
    Eriksson AM; Leikfoss IS; Abrahamsen G; Sundvold V; Isom MM; Keshari PK; Rognes T; Landsverk OJB; Bos SD; Harbo HF; Spurkland A; Berge T
    Scand J Immunol; 2021 Jul; 94(1):e13050. PubMed ID: 34643957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients.
    Márquez A; Varadé J; Robledo G; Martínez A; Mendoza JL; Taxonera C; Fernández-Arquero M; Díaz-Rubio M; Gómez-García M; López-Nevot MA; de la Concha EG; Martín J; Urcelay E
    Eur J Hum Genet; 2009 Oct; 17(10):1304-8. PubMed ID: 19337309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians.
    Bashinskaya VV; Kulakova OG; Kiselev IS; Baulina NM; Favorov AV; Boyko AN; Tsareva EY; Favorova OO
    J Neuroimmunol; 2015 May; 282():85-91. PubMed ID: 25903733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.
    Fransen NL; Crusius JBA; Smolders J; Mizee MR; van Eden CG; Luchetti S; Remmerswaal EBM; Hamann J; Mason MRJ; Huitinga I
    Brain Pathol; 2020 Jan; 30(1):106-119. PubMed ID: 31228212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.